The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

Mixed options sentiment in Moderna (MRNA), with shares down 94c near $23.98. Options volume relatively light with 49k contracts traded and calls ...

A bipartisan report warned Congress about China’s growing control over the pharmaceutical supply chain. Elsewhere, Alkermes sweetened its bid for Avadel and Moderna is investing $140 million in U.S.

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a ...

Moderna is investing more than $140 million to bring drug manufacturing to its Massachusetts campus, a move that it says will ...

Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...